More articles from 05.01 - Airway pharmacology and treatment

RCT Abstract - Airway smooth muscle mass to predict response to ICS in COPD patients receiving triple therapy (HISTORIC study): a randomized, placebo-controlled, double-blind, investigator-initiated trial
Daiana Stolz, Eleni Papakonstantinou, Maria Pascarella, Kathleen Jahn, Aline Siebeneichler, Andrei Darie, Matthias Herrmann, Werner Strobel, Anna Salina, Leticia Grize, Michael Tamm

European Respiratory Journal Sep 2022, 60 (suppl 66) OA9001; DOI: 10.1183/13993003.congress-2022.OA9001
Bronchodilators in Symptomatic Tobacco-exposed Persons with Preserved Spirometry for the RETHINC Study Group
MeiLan K. Han, Wen Ye, Di Wang, Emily White, Mehrdad Arjomandi, Igor Barjaktarevic, Stacey-Ann Brown, Russell Buhr, Alejandro Comellas, Christopher Cooper, Gerard Criner, Mark Dransfield, Frank Drescher, Rodney Folz, Nadia Hansel, Robert Kaner, Richard Kanner, Jerry Krishnan, Stephen Lazarus, Veeranna Maddipati, Fernando Martinez, Anne Matthews, Catherine Meldrum, Charlene Mcevoy, Toru Nyunoya, Linda Rogers, William Stringer, Christine Wendt, Robert Wise, Stephen Wisniewski, Frank Sciurba, Prescott Woodruff

European Respiratory Journal Sep 2022, 60 (suppl 66) RCT712; DOI: 10.1183/13993003.congress-2022.RCT712
Dose response of icenticaftor in patients with COPD and chronic bronchitis on triple inhaled therapy
Frits M.E. Franssen, Fernando J. Martinez, Jadwiga A. Wedzicha, Joerg H. Eckert, Barbara Knorr, Rutvick Parlikar, Ana-Maria Tanase, Christian Gessner

European Respiratory Journal Sep 2022, 60 (suppl 66) RCT710; DOI: 10.1183/13993003.congress-2022.RCT710
Evaluating multiple eosinophil measurements when stepping up to ICS/LAMA/LABA triple therapy in patients with COPD: a post-hoc analysis of ETHOS
D Singh, M Bafadhel, J R Hurst, P Darken, M Patel

European Respiratory Journal Sep 2022, 60 (suppl 66) 4346; DOI: 10.1183/13993003.congress-2022.4346
Prevalence of anxiety and depression in patients with severe Asthma who are receiving biologic therapy
J Watson, C Peach, N Price, J Evans, A Draper, S Ruickbie

European Respiratory Journal Sep 2022, 60 (suppl 66) 4192; DOI: 10.1183/13993003.congress-2022.4192
Understanding how azithromycin reduces asthma exacerbations and the underlying mechanisms of macrolides
L Jurak, I Yang, M Hill, J Simpson, J Upham

European Respiratory Journal Sep 2022, 60 (suppl 66) 4372; DOI: 10.1183/13993003.congress-2022.4372
Impact of erdosteine on exacerbations in moderate COPD
P M A Calverley, A Papi, C Page, P Rogliani, R Dal Negro, M Cazzola, A Cicero, W Wedzicha

European Respiratory Journal Sep 2022, 60 (suppl 66) 4365; DOI: 10.1183/13993003.congress-2022.4365
Identification and characterisation of selective antagonists for TMEM16A(acd) isoform for the treatment of obstructive respiratory diseases
P P saintot, C Carignani, J Phillips, C Virginio

European Respiratory Journal Sep 2022, 60 (suppl 66) 4414; DOI: 10.1183/13993003.congress-2022.4414
Safety of ascending single and multiple doses of inhaled SIS, an isotonic aqueous solution of sodium hypochlorite, in healthy subjects
C Burton, T Balchen, L Wilki-Kurtzhals, N Sjögren, T Bjarnsholt, E Jørgensen, D P Sonne

European Respiratory Journal Sep 2022, 60 (suppl 66) 4333; DOI: 10.1183/13993003.congress-2022.4333
Gender differences in gene polymorphisms are linked to up-reguated leukotriene pathway in asthma
D Mirra, R Esposito, G Spaziano, E Cione, L Gallelli, F Roviezzo, F Polverino, B D'Agostino

European Respiratory Journal Sep 2022, 60 (suppl 66) 4663; DOI: 10.1183/13993003.congress-2022.4663

Main menu

User menu

Search

More articles from 05.01 - Airway pharmacology and treatment

Pages

Contact us